Neoadjuvant Chemo-irradiation in un-resectable Carcinoma of Rectum
AbstractBackground: Rectal cancer is one of the most frequent gastrointestinal cancers. Conventionally surgery is the mainstay of treatment, however after surgery alone, local recurrence is high especially in locally advanced rectal cancer, i.e. tethered and fixed rectal cancer. This study was conducted to determine the role of neo-adjuvant (pre-operative) chemo-irradiation in locally advanced carcinoma of the rectum to improve resectability , local control and survival. Methods: Study was conducted in Radiation Oncology department of Shaukat Khanum Memorial Cancer Hospital and Research Center from May 97-Oct 99. Thirteen patients with unresectable/ locally advanced adenocarcinoma rectum received neo-adjuvant chemoirradiation, 50 Gray to pelvis by box technique on Cobalt-60 machine with concomitant 5-Flurouracil 500mg/m2 for first three and last three days followed by abdomino-perineal /low anterior resection. Results: Neo-adjuvant chemoirradiation resulted in resectability rate of 92% and clinical down staging in 11/13 (84%) patients and pathological complete response in 2/13 (15%) patients and a local recurrence rate of 2/13 (15.38%). Non hematological toxicity (diarrhea grade 4-15%, erythema grade3-23%, dysuria grade1-2-38%) were main problems observed during neo-adjuvant chemoirradition. Conclusion: Concomitant preoperative chemoirradiation for locally advanced rectal cancer is associated with considerable clinical and pathological down staging. Tumor resectability is improved with potential for improved local control and is relatively safe with acceptable morbidity.KEY WORDS: Unresectable rectal cancer, resectibility rate, neo-adjuvant chemoirradiation
Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Cancer 1974;34:1278-92.
McDermott FT, Hughes ESR, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1982;72:2735.
Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerhan DL et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer ; Results from NSABP protocol R-01. Natl Cancer Inst 1988;80:21-9.
Thomas PRM, Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma; a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol 1988;13:245-52.
Duncan W, Smith AN, Freedman LF. Third report of an Medical Research Council working party. Clinico-pathological features of prognostic significance in operable rectal cancer in 17 centres in the U.K. Br J Cancer 1984;50: 435-42.
Vauthey JN, Marsh RW, Zlotecki RA. Recent advances in the treatment and outcome of locally advance rectal cancer. Ann Surg 1999;229:745-52.
Gerard A, Buyse M, Nordlinger B. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surgery 1988;208:606-14.
Stockholm Rectal Cancer Study Group. Short-term preoperative radiotherapy for adenocarcinoma of the rectum. An interim analysis of a randomized multicenter trial. Am J Clin Oncol 1987;10:369-75
Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
Pahlman L, Glimelius B. Pre-or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990;211:187-95.
Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez, N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery; Trial of the European Organization on Research & Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer 1984;53:1811-8.
Alexander Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:791-9.
Haghbin M, Sicchy B, Hinson J. Combined modality preoperative therapy in poor prognostic rectal adenocarcinoma. Radiother Oncol 1988;13:75-81.
Siscy B. The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 1985;11:1587-93.
Janjan NA, Crane CN, Feig BW. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000;47:713-8.
Minsky BD, Cohen AM, Kemeny N. Enhancement of radiation induced downstaging of rectal cancer by fluorouracil and high-dose Leucovorin chemotherapy. J Clin Oncol 1992;10:79-84.
Frykholm G, Glimelius B, Pahlman L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primarily non-resectable adenocarcinoma of the rectum. Results from two consecutive studies. Eur J Cancer Clin Oncol 1989; 25:1535-54.
Mendenhall WM, Bland KI, Pfaff WW, Million RR, Copeland-III EM. Initially unresectable rectal and surgery. Ann Surg 1987;205:41-44 .
Dosoretz DE, Gunderson LL, Hedberg S, Hoskins B, Blitzer P Hl, Shipley W et al. Preoperative irradiation for un-resectable rectal and rectosigmoid carcinomas. Cancer 1983;52:814-8
Valentini V, Coco C, Cellini N. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 1998;40:1067-75
Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169-75.
Minsky BD, Kemeny N, Cohen A M, Enker WE, Kelsen DP, Reichman B et al. Preoperative high-dose Leucovorin/5-Fluorouracil and radiation therapy or unresectable rectal cancer. Cancer 1991;67:2859-66
Mohiuddin M, Marks G. High dose preoperative irradiation for cancer of the rectum 1976-1988. Int J Radiat Oncol Biol Phys 1991;20:37-43.
Horn A, Morild I, Dahl O. Tumour shrinkage and downstaging after preoperative radiation of rectal adenocarcinomas. Radiother Oncol 1990;18:9-28.
Haghbin M, Sischy B, Hinson J. Combined modality preoperative therapy in poor prognostic rectal adenocarcinoma. Radiother Oncol 1988;13:75-81.
Kaminsky-Forrett MC, Conroy T, Luporsi E. Prognostic implications of down staging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;42: 935-41.
Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997;336:980-7.
Grann A, Minsky BD, Cohen AM. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997;40:515-22.
Chari RS, Tyler DS, Anscher MS. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778-86.
Rich TA, Skibber JM, Ajani JA. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025-9
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.